Background*

Dr. Richard Ogden, Ph.D., CSCS, served as the Chief Scientific Officer at Cannabis Science, Inc. Dr. Ogden serves as Member of Scientific Advisory Board of Tobira Therapeutics Inc. and has been its Scientific Development Advisor since August 2007 and Consultant. Dr. Ogden is a Co-Founder of RORR Enterprises. Dr. Ogden serves as Senior Counselor at Hyde Park Communications, Inc. Dr. Ogden served as Senior Director for Scientific Affairs, HIV and US Medical of Pfizer Inc. ... Dr. Ogden served as Medical Advisor of Muscle Pharm Corp. He joined Agouron Pharmaceuticals, Inc. in 1984 and served as its Senior Scientist, Group Leader of Medicinal Chemistry, Principal Scientist, Manager of New Projects Research and Senior Director of Scientific Development. He served as the Scientific Liaison for the Agouron/Pfizer commercial & corporate organizations, assisting in the launch of, and continued support of the protease inhibitor Viracept. Dr. Ogden's extensive knowledge and experience in launching HIV medications for global pharmaceutical companies offers MusclePharm a considerable benefit as venture into the clinical realm of therapeutic nutritional supplementation with innovative whey protein product, MuscleGel(R). Dr. Ogden was a Team Member in the discovery and development of the early protease inhibitor Nelfinavir (Viracept(R)). He assisted in the clinical launch of Nelfinavir (Viracept(R)), providing medical education in the HIV/AIDS clinical and patient communities, along with the evaluation of proposals for post marketing clinical research in the HIV/AIDS area. He also supported the pre-marketing activities for many other clinical agents in the HIV/AIDS and oncology therapeutic areas. Dr. Ogden served as a representative on the International AIDS Society Industry Liaison Forum. He serves as a Member of the Clinical and Science Advisory Board of Presidio Pharmaceuticals, Inc. Dr. Ogden served as a Member of Advisory Board of Muscle Pharm Corp. since April 11, 2011. Dr. Ogden has written for numerous scientific and educational publications. He has also co-edited a book on Protease Inhibitors in AIDS Therapy and a book on Reverse Transcriptase Inhibitors in AIDS Therapy as well. Dr. Ogden received his Bachelor's Degree in Natural Sciences from Cambridge University. Dr. Ogden holds M.A. in Chemistry and Ph.D in synthetic Organic Chemistry from Cambridge University in England.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.